Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 53996

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Bhanu K Bhakhri

"The Journal of Clinical and Diagnostic Research (JCDR) has been in operation since almost a decade. It has contributed a huge number of peer reviewed articles, across a spectrum of medical disciplines, to the medical literature.
Its wide based indexing and open access publications attracts many authors as well as readers
For authors, the manuscripts can be uploaded online through an easily navigable portal, on other hand, reviewers appreciate the systematic handling of all manuscripts. The way JCDR has emerged as an effective medium for publishing wide array of observations in Indian context, I wish the editorial team success in their endeavour"



Dr Bhanu K Bhakhri
Faculty, Pediatric Medicine
Super Speciality Paediatric Hospital and Post Graduate Teaching Institute, Noida
On Sep 2018




Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dematolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2012 | Month : April | Volume : 6 | Issue : 2 | Page : 226 - 230

Evaluation of the Anti-nociceptive and Anti-inflammatory Activities of the Pet: Ether Extract of Portulaca Oleracea (Linn.)

Jagan Rao N., Jayasree T., Mallikarjuna Rao B., Sandeep Kumar K., Vijay Kumar S.

1. Department of Pharmacology, Meenakshi Medical College and RI, Kanchipuram, India. 2. Department of Pharmacology, Mamata Medical College, Khammam-507002, A.P, India. 3. Department of Pharmacology, Padmashri Dr. Vithalrao Vikhe Patil Foundation’s Medical College, Ahmednagar, India. 4. Department of Pharmacology, Meenakshi Medical College and RI, Kanchipuram, India. 5. Department of Pharmacology, Meenakshi Medical College and RI, Kanchipuram, India.

Correspondence Address :
Jagan Rao N., Department of pharmacology,
Meenakshi Medical College and RI, Kanchipuram,
Tamil Nadu, India.
Phone: (0) 8122382042.

Abstract

To investigate the ant-inociceptive and the anti-inflammatory activities of the petroleum-ether extract of Portulaca oleracea.The petroleum-ether extract of Portulaca oleracea was subjected to a preliminary phytochemical screening. Acute toxicity studies were carried out in Swiss albino mice. The analgesic activity of the petroleum-ether extract of Portulaca oleracea was evaluated by using well established models like acetic acid induced writhing, the formalin test and the tail immersion method in mice. Its acute anti-inflammatory effect was studied by the Carrageenan induced hind paw oedema method in rats. Its phytochemical evaluation revealed the presence of alkaloids, tannins, flavonoids, saponins and triterpenoids. The acute toxicity studies showed that the extract was non-toxic upto a maximum dose of 2000 mg/kg body weight. The petroleum-ether extract exhibited significant inhibition of the acetic acid induced writhing, it reduced the paw-licking response time significantly in the formalin test and it increased the withdrawal latency time in the tail immersion test. The Carrageenan induced hind paw oedema was significantly reduced in rats. The present study indicated that the petroleum-ether extract of Portulaca oleracea had potential ant-inociceptive and anti-inflammatory activities.

Keywords

Portulaca oleracea (Linn.), petroleum-ether extract, anti-nociceptive, antiinflammatory

Introduction
The classical NSAIDs (aspirin like drugs) are among the most widely prescribed drugs worldwide as analgesic and anti-inflammatory agents and they have become an important weapon in the control of inflammation and the pain which is associated with musculoskeletal pathologies like; rheumatoid arthritis, osteoarthritis, gout, tendonitis, muscle strain, post-operative and post-traumatic inflammation, thrombophlebitis and vasculitis. Being the drug of choice for the treatment of rheumatic disorders and other degenerative inflammatory diseases or being an abused drug, the consumption of NSAIDs has been rated as high as compared to that of other drugs. However, their prolonged clinical use is hampered by their side effects, most notably, gastric erosion, ulceration, haemorrhage, bronchospasm and kidney and liver dysfunction (25). This has been the rationale behind the development of new analgesic and anti-inflammatory drugs. The search for novel molecules has been extended to herbal drugs that offer better protection against pain and inflammation with minimal unwanted effects.

Portulaca oleracea (P. oleracea) which belongs to the family “Portulacaceae”, is a herbaceous plant which is widely distributed throughout the world. It contains many biologically active compounds and it is a source of many nutrients like free oxalic acids, alkaloids, omega-3 fatty acids, coumarins, flavonoids, cardiac glycosides, anthraquinones, proteins (11), a-linolenic acid, b-carotene [17, 4] mono terpene glycoside (27) and N-trans-feruloyltyramine (19). It has also been found to contain vitamin C, oleoresins-I and II, saponins, tannins, saccharides, triterpenoids, 0a-tocopherol and glutathione [6,28,22]. The high contents of a variety of phytoconstituents which are present in this plant have been considered to be responsible for the biological activities which have been reported as characteristic of this plant like antibacterial, antifungal (21), anti-fertility (30), muscle relaxant (23) and wound healing properties (24) (This plant which is normally used as aArticlevegetable to prepare curry by the native people of Andhra Pradesh has been used in combination with tomato. Previous studies have revealed the above mentioned pharmacological properties of Portulaca oleracea. However, no study was done to assess the combination of the analgesic and the anti-inflammatory activities of the petroleum-ether extract of Portulaca oleracea. Therefore, the present study was designed to investigate the petroleum-ether extract of Portulaca oleracea for its ant-inociceptive and anti-inflammatory activities.

Material and Methods

The leaves of Portulaca oleracea were collected from a local vegetable market in Kanchipuram in the month of January 2011. The identification and the authentication of this plant were done at the Department of Botany, Government Degree College, Kanchipuram.

Animals Swiss albino mice (25-30g) and male Wistar rats (150-175 g) were procured from the institutional animal house. The animals had free access to the standard pellet feed (Provomi) and water ad libitum under strict hygienic conditions, and they were maintained at a room temperature of 25 ± 1°C; a relative humidity of 45-55% and in 12:12 light/dark cycles. All the experiments were conducted in strict compliance according to the ethical principles and the guidelines which were provided by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). The study protocol was approved by the institutional animal ethical committee (T.C/COL/2331/2011/HOSF-378).

Preparation of the Extract The Portulaca oleracea leaves were shade dried and one kg of coarse powder was soaked in 4 liters of petroleum-ether for 3 daysat room temperature. The cold macerate was extracted by using the Soxhlet apparatus. The extract was evaporated to dryness by using a rotary vacuum flask evaporator and the yield was10% w/w.

Phytochemical Screening The petroleum-ether extract from the Portulaca oleracea leaves was subjected to a qualitative chemical investigation for the identification of its phyto constituents (14) like triterpenoids, saponins, alkaloids, carbohydrates, tannins, flavonoids and glycosides by using the appropriate reagents. The extracts were treated with dilute hydrochloric acid and filtered. The filtrate was used for the following tests.

Test for Alkaloids (Mayer’s Test) The extract was treated with Mayer’s reagent and the appearance of a cream colour indicated the presence of alkaloids. Test for Tannins The extract was treated with 10% lead acetate solution; the appearance of a white precipitate indicated the presence of tannins. Test for Flavonoids (Shinoda Test) In the extract, 5ml of 95% ethanol, few drops of conc. HCl and 0.5g of magnesium turnings were added. The formation of a pink colour indicated the presence of flavonoids. Test for Saponins (Froth Test) 1ml of the extract was diluted to 20 ml with distilled water and this was shaken well in a test tube. The formation of foam in the upper part of the test tube indicated the presence of saponins. Test for Terpenoids (Salkowski Test) 5ml of the extract was mixed in 2 ml of chloroform, and concentrated H2S04 (3 ml) was carefully added to form a layer. A reddish brown colouration of the inter face which was formed indicated the presence of terpenoids.

Test for Carbohydrates (Molisch’s Test) The extract was treated with 3ml of alpha–napthol in alcohol and concentrated sulphuric acid was added along the sides of the test tube carefully. The formation of a violet coloured ring at the junction of the two liquids indicated the presence of carbohydrates. Test for Glycosides (Modified Borntrager’s Test) To 5 ml of the extract, 5ml of 5% FeCl3 and 5ml of dil. HCl were added. This was heated for 5 min. in a boiling water bath. It was then cooled and benzene or any organic solvent was added to it. The mixture was shaken well. The organic layer was separated and an equal volume of dil. Ammonia was added to it. The ammoniacal layer showed a pinkish red colour. Acute Toxicity Studies Acute oral toxicity studies were performed according to the Organization for Economic Cooperation and Development (OECD 423) guidelines (12) . Albino mice of either sex which weighed 25-30 g and which were of 90 days of age were used to determine the LD50 of the petroleum-ether extract of Portulaca oleracea. Tween-80 1% v/v was used as vehicle to suspend the petroleum-ether extract.The petroleum-ether extract was administered in a dose of 2g/kg orally to a group of three mice. The animals were continuously observed for changes in their autonomic or behavioural responses for 6 hours. The animals were kept under observation for 14 days to detect any mortality. The petroleum-ether extract was found to be non-toxic with a dose of up to 2g/kg of body weight.

Antinociceptive Activity The acetic acid induced writhing, formalin induced nociception and the hot water tail immersion methods were used to evaluate the potential ant-inociceptive activity of the petroleum-ether extract of the leaves of Portulaca oleracea. The petroleum-ether extract was prepared as a suspension in 1% Tween 80 and it was administered orally to the experimental animals. A group of animals was treated with the vehicle (1% Tween 80) and this served as the control group. Morphine (5mg and 10mg/kg sc) was used as a standard drug for comparison. Acetic Acid Induced Abdominal Constriction The mice were treated with the petroleum ether extract of Portulaca oleracea in different doses (50,100 and 200 mg/kg) per oral. Sixty minutes later, acetic acid (0.6% v/v in saline) was injected intra-peritoneally in a dose 10ml/kg15. The number of abdominal constrictions (writhing) in the mice was counted for 15 min following the acetic acid injection. Any significant reduction in the number of abdominal constrictions by the treatment as compared to that in the vehicle treated animals was considered as an ant-inociceptive response. The percentage inhibition of the writhings as compared to the vehicle treatment was calculated by using the formula, (C-T/C) x100 where C is the number of abdominal constrictions which were recorded in the vehicle treated animals and T is the number of abdominal constrictions in the treatment group. The highest dose which was employed (200mg/kg) was chosen for further ant-inociceptive assessments.

Formalin-induced Paw-licking 20 microlitres of 1% formalin in saline was administered s.c. in the plantar surface of the left hind paw of mice (9) 60 min after the treatment with the petroleum-ether extract of Portulaca oleracea (200mg/kg).The time which was spent in licking or biting the injected paw was recorded every 5 min for a period of 30 minutes and it was considered as the response to the nociception. The early phase of the nociceptive response normally peaks from 0-10 min and the late phase normally peaks from 10-30 min after the formalin injection. The paw licking time in the mice after the petroleum-ether extract/morphine (5mg/kg) treatment was compared with that in the vehicle treated mice. The percent inhibition of the paw licking time as compared to the vehicle treatment was calculated by using the formula, Percent inhibition = C-T/Cx100, where C was the biting/paw licking response time (seconds) in the vehicle treated group and T was the biting/paw licking response time (seconds) in the petroleum-ether treated group.

The Tail Immersion Test The tail immersion test (26) was used to evaluate the anti-nociceptive activity of Portulaca oleracea in a dose of 200mg/kg p.o. The tail of a mouse was immersed in a water bath which was maintained at 55 ± 0.5°C. The time for the withdrawal of the tail was taken as the reaction time. A cut off period of 10 seconds was maintained. The reaction time was measured just before the administration of the test substances (0 min) and then at intervals of 30 min up to a period of 90 min. The increase in the latency period was compared to that in the vehicle treated group. Morphine, in a dose of 10mg/kg s.c, was used as a standard drug.

Antiinflammatory Activity Carrageenan-induced Hind Paw Oedema: Male Wistar rats (150-175 g) were fasted overnight and the paw oedema was developed by injecting carrageenan 0.1ml of 1% w/v suspension in sterile normal saline into the subplantar tissue of the right hind paw (32). One hour before the carrageenan injection, the petroleum-ether extract of Portulaca oleracea which was suspended in Tween 80 was administered orally in a dose of 200mg/kg .The control group of rats received 1% Tween 80 v/v 1ml/100gm per oral. Another group of rats was administered the standard drug diclofenac 10mg/kg i.p 30 minutes prior to the carrageenan injection. The diameter of the paw was measured by using digital Vernier calipers before the administration of carrageenan and at 1, 2, 3, 4, 5 and 6 hour intervals after the administration of carrageenan. The thickness of the oedema in (mm) at various time intervals was calculated by subtracting the zero hour reading. The oedema (DT) was calculated as follows, DT=Tt-T0 Tt is the right hind paw thickness in mm at time t T0 is the right hind paw thickness before the sub-plantar carrageenan injection The % reduction of the oedema was calculated as follows, Mean oedema in the untreated control group (C) – mean oedema in the drug treated group (T) / Mean oedema in the untreated control group×100 = (C-T/C×100)

Statistics The data were expressed as mean ± standard error of the mean (S.E.M).The results were analyzed by One Way Analysis of Variance, followed by the Post hoc Bonferroni Test. A value of p<0.05 was considered as significant.

Results

Phytochemical Screening The percentage yield of the petroleum-ether extract of the leaves of Portulaca oleracea was found to be 10.6% w/w. The chemical tests indicated the presence of phytoconstituents like flavonoids, tannins, saponins, terpenoids and alkaloids in the petroleum-ether extract. Acute Toxicity Studies There was no significant alteration in the autonomic or the behavioural responses in the mice which were treated with the pet-ether extract of the leaves of Portulaca oleracea. No mortality was recorded in these animals for up to 14 days. Antinociceptive Activity A cetic acid induced abdominal constrictions: The mean number of abdominal constrictions in the vehicle treated control animals was 36.50 ± 0.42 (Table/Fig 1). A significant reduction in the number of abdominal constrictions was recorded for the morphine treated mice, the mean value being 4.83 ± 0.54 and the percentage inhibition of nociception being 86.76%. A dose dependent reduction in the number of abdominal constrictions was noticed after the administration of the petroleum ether extract of Portulaca oleracea.The reduction was significant with 100mg/kg (30.45 ± 0.56) and 200mg/kg (14.83 ± 1.49) of the extract. In the above doses, the percentage inhibitions of nociception were 16.57% and 59.36% respectively.

Formalin-induced Nociception In the vehicle treated control animals, the paw licking response time was 46.33 ± 2.6 in the early phase (0-10 min) and it was 85.8 ± 3.58 in the late phase (10-30 min). In the morphine treated animals, the paw licking response time was significantly reduced, both in the early (10 ± 0.73) and the late phases (3.33 ± 0.49). A significant reduction in the paw licking response time was evident in the early phase (37.16 ± 1.16) and in the late phase (27.33 ± 5.31) after the treatment with the pet-ether extract of Portulaca oleracea. The extract nearly produced 19% and 33% inhibitions of the nociceptive response in the early and late phases respectively (Table/Fig 2).

The Tail Immersion Test The mean reaction time in the vehicle treated mice during the observation periods (30, 60 and 90 mts) were 1.78 ± 0.03, 1.73 ± 0.07 and 1.76 ± 0.02 respectively (Table/Fig 3). The Morphine treatment significantly increased the reaction time in all the observation periods. The reaction time with the 200 mg/kg pet-ether extract of Portulaca oleracea was also significantly increased as compared to that in the vehicle treated mice. It showed the maximum latency period at the 60th minute. Carrageenan Induced Hind Paw Oedema Intra-plantar carrageenan administration increased the diameter of the paw significantly over the period of observation in the vehicle treated control animals (Table/Fig 4).This increase was significantly lesser at all the observation periods with indomethacin treatment. A maximum of 48% inhibition was observed at five hours. In a similar fashion, the treatment with the pet-ether extract of Portulaca oleracea also reduced the increase in the paw diameter due tothe carrageenan administration. A maximum of 26% inhibition was observed at the 5th hour.

Discussion

The present study was undertaken to scientifically validate the traditional claims of Portulaca oleracea with particular references to its ant-inociceptive and anti-inflammatory effects by different methods, viz. visceral nociception (acetic acid induced abdominal constriction), thermal nociception (tail immersion test) and neurogenic and inflammatory nociception (formalin induced paw licking) and to its anti-inflammatory effect (the carrageenan induced hind paw oedema test). In the acute toxicity testing, no mortality was observed in the mice, even in a dose of 2g/kg of pet-ether extract of Portulaca oleracea, which indicated the safe nature of the extract.

The acetic acid induced abdominal constriction (15) method is a very sensitive one and it can detect the anti-nociceptive effect of substances at a dose that cannot be detected by other methods such as the tail-flick test (5). The abdominal constriction responses were found to partly involve the local peritoneal receptors (3). This method has been associated with prostanoids in general; e.g increased levels of PGE2 and PGEF2α in the peritoneal fluids (7) as well as lipoxygenase products which were reported by some researchers [16,8]. The mean number of abdominal constrictions after the acetic acid injection in the mice was significantly (P<0.05) reduced by the pet-ether extract of Portulaca oleracea, either due to the inhibition of prostaglandins or due to leukotriene synthesis.

The formalin induced paw licking was a persistent-pain model which was used to evaluate the neurogenic and inflammatory nociception in 2 phases (i.e.) in the early (0-10 mts) and the late phases (10-30 mts) respectively. The early phase of the formalin response was attributed to the direct stimulation of the nociceptors [9,13,29]. The late phase was the result of an inflammatory reaction whichwas caused by tissue injury, leading to the release of histamine, serotonin, prostaglandin and excitatory amino acids. The centrally acting analgesic drugs like the narcotic analgesics inhibit both the phases equally, while the peripherally acting drugs such as steroids and NSAID’s suppress mainly the late phase. The pet-ether extract of Portulaca oleracea markedly attenuated the formalin induced paw licking response time in the late phase as compared to that in the early phase. This revealed that Portulaca oleracea may be more effective in alleviating the pain which was caused by inflammation.

The carrageenan induced paw-oedema model has gained greater importance and support over the years, because the oedema which is induced by carrageenan is reported to have been inhibited by a majority of the steroidal and the non-steroidal anti-inflammatory drugs. Moreover, the lesions which were induced by carrageenan have been said to resemble those of rheumatoid arthritis histologically in human beings, at least to a certain extent. These observations have justified the use of carrageenan as the prime oedemogen. It has a biphasic effect. The first phase (0-3hr) is due to the release of histamine and serotonin, the plateau phase is maintained by a kinin like substance (3hours) and the late phase (4.5-5hr) of the inflammation is attributed to prostaglandin release (31). In the intial phase, the mast cells are activated and degranulated, thus releasing histamine and serotonin. These mediators increase the vascular permeability of the blood vessels, which facilitates the infiltration of neutrophils and the accumulation of plasma fluids and proteins into the interstitial spaces. This is followed by the release of kinins after a certain time. These events lead to the development of oedema which is reduced by anti-inflammatory agents. The drugs which inhibit the initial phase of the carrageenan induced hind paw oedema indicate that they exert an anti-inflammatory effect. The oedema in the late phase is due to a massive infiltration of neutrophils and the overproduction of prostaglandin. NSAIDs predominantly inhibit the late phase of the inflammation in the carrageenan induced hind paw oedema.

The administration of the Portulaca oleracea extract consistently reduced the paw oedema in rats after the carrageenan administration [Table/Fig-4].This observation indicated the potent anti-inflammatory effect of the pet-ether extract of Portulaca oleracea.Thus, the present study revealed the potential analgesic and anti-inflammatory effects of the pet-ether extract of Portulaca oleracea.

The phytochemical screening of the pet-ether extract of Portulaca oleracea revealed the presence of flavonoids, tannins, saponins, terpenoids and alkaloids. The phytochemical constituents are physiologically active compounds which possess a great potential for therapeutic and prophylactic uses. The analgesic and the anti-inflammatory effects of flavonoids, tannins and saponins have been reported [10,1]. The anti-inflammatory activity of flavonoids may be mainly due to the inhibition of the prostaglandin synthesis [20,1,2].

Terpenoids have also been reported to possess anti-inflammatory, anti-oxidant and neuroprotective activities (18). Hence, the analgesic and the anti-inflammatory effects which were produced by the extract may be attributed individually or collectively to the flavonoids, tannins, terpenoids and the saponins.

Conclusion

From the present study, it is quite apparent that the petroleumether leaf extract of Portulaca oleracea possesses significant analgesic and anti-inflammatory effects against different stimuli. This was evidenced by a significant increase in the reaction time by the stimuli in different experimental models and by the significant analgesic and anti-inflammatory activities. Apart from the huge number of research studies in the field of analgesic and anti-inflammatory discoveries, this field still needs more attention from scientists around the world.

References

1.
Ahmadiani A, Fereidoni M, Semnanian S, Kamalinejad M, Saremi S. The anti-noceptive and the anti-inflammatory effects of the Sambucus ebulus rhizome extract in rats. J. Ethnopharmacol, 1998; 61:229-35.
2.
Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M, Saremi S. The ant-inociceptive and the antiinflammatory effects of the Elaeagnus angustifolia fruit extract. J. Ethnopharmacol, 2000; 72:287–92.
3.
Bentley GA, Newton SH, Starr J. Evidence for an action of morphine and the enkephallins can sensory nerve endings in the mouse peritoneum. Brit. J. Pharmacol, 1981; 79: 125-34.
4.
Barbosa-Filho JM, Alencar AA, Nunes XP, Tomaz AC, Sena Filho JG, Athayde Filho PF. Sources of alpha, beta, gamma, delta and epsilon-carotenes: A twentieth century review. Rev Bras Farmacogn 2008; 18:135-54.
5.
Collier HOJ, Dinneen LG, Johnson CA, Schneider C. The abdominal constriction response and its suppressesion by analgesic drugs in mice. Brit. J. Pharmacol 1968; 32: 295-310.
6.
Chatterjee A, Chandra S, Pakrashi. The treatise on Indian medicinal plants. Publ Inform Directorate 1956; 1:243-44.
7.
Derardt R, Jougney S, Delevalcee F, Falhourt M. The release of prostaglandins E and F in an algogenic reaction and its inhibition. European Journal of Pharmacology, 1980; 51: 17-24.
8.
Dhara AK, Suba V, Sen T, Pal S, Nag Chaudhuri AK. Preliminary studies on the anti-inflammatory and the analgesic activities of the methanolic fraction of the root extract of Tragia involucrate. J. Ethanopharmacology, 2000; 72:265-68.
9.
Dubuisson, Dennis SG. The formalin test: A quantitative study on the analgesic effects of morphine and meperidine and on the brainstem stimulation in rats and cats. Pain, 1977; 4: 161-74.
10.
Das PC, Das A, Mandals S. Fitotherapy.1989; 60: 235-40.
11.
Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive characterization of the purslane accessions as was influenced by the planting date. Plant Foods Hum Nutr 1999; 54:183-91.
12.
Ecobichon DJ. The basis of toxicology testing. CRC press, New York: 1997; 43-86.
13.
Hunskaar S, Hole K. The formalin test in mice: the dissociation between inflammatory and non-inflammatory pain. Pain: 1987; 30: 103-14.
14.
Khandelwal KR. Practical Pharmacognosy Techniques and Experiments. 2000, Pune, India, Nirali Prakashan.
15.
Koster R, Anderson M, DeeBeer AJ. Acetic acid for analgesic screening. Fed Proc: 1959; 18: 412-16.
16.
Levini JD, Lau W, Kwait G, Goetzl EJ. Leukotriene B4 produces hyperalgesia that is dependent on the polymorphonuclear leucocytes. Science 1984; 255: 743-45.
17.
Liu LX, Howe P, Zhou YF, Xu ZH, Hocart C, Zhang R. Fatty acids and b-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr 2000; 893:207-13.
18.
Mu L, Kou J, Zhu D, Yu B. Comparison of the neuroprotective effects of flavonoids and terpenoids, and their combinations from ginkgo bilobaon ischemia-reperfusion-injured mice. Pharmaceutical Biology 2007; 45:728-33.
19.
Mizutani M. Factors which are responsible for inhibiting the mortality of the zoospores of the phytopathogenic fungus, Aphanomyces cochlioides, which was isolated from the non-host plant, Portulaca oleracea. FEBS Lett 1998; 438:236-40.
20.
Meher BR, Rath BG, Biswal S. J. Chem. Pharm. Res., 2011; 3(3): 831-34.
21.
Oh KB, Chang IM, Hwang KI, Mar W. Detection of the anti-fungal activity of Portulaca oleracea by using a single cell bioassay system. J Phytother Res 2002; 14:329-32.
22.
Prashanth KL, Jadav H, Thakurdesai P, Nagappa AN. The cosmetic potential of herbal extracts. Nat Prod Radiat 2005; 4:351.
23.
Parry O, Marks JA, Okwuasab FK. The skeletal muscle relaxant action of Portulaca oleracea: the role of potassium ions. J. Ethnopharmacol 1993; 49:187-94.
24.
Rasheed AN, Affif FU, Disi AM. Simple evaluation of the wound healing activity of the crude extracts of Portulaca oleracea in Mus musculus JVJ-1. J Ethnopharmacol 2003; 68:131-6.
25.
Soll AH. Non-steroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern Med., 1991; 114:307-19.
26.
Sewell RDE, Spencer PSJ. Antinociceptive activity of narcotic agonists and partial agonists, analgesics and other agents in the tail immersion test in mice and rats. Neuropharmacology 1976; 15: 683.
27.
Sakai NK, Okamoto, Shizuru Y, Fukuyama Y, Portuloside A. A monoterpene glucoside from Portulaca oleracea. Phytochemistry 1996; 42:1625-28.
28.
Simopoulous AP, Norman HA, Gillaspy, Duke JA. Common purslane: A source of omega-3 fatty acids and anti-oxidants. J Am Coll Nutr 1992; 11:374-82.
29.
Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992; 51:5-17.
30.
Verma OP, Kumar S, Chatterjee SN. Anti-fertility effects of the common edible Portulaca oleracea on the reproductive organs of male albino mice. Indian J Med Res 1982; 75:301-10.
31.
Vane JR, Botting BM. Overview, the mechanism of action of antiinflammatory drugs. In Vane JR Botting ends. Clinical significance and the potential of the selective COX-2 inhibitors. London: William Harvey Press: 1998;1-18.
32.
Winter CA, Risley EA, Nuss GW. Carrageenan induced oedema in the hind paw of rats as an assay for anti-inflammatory drugs. Proc Soc Exp.Biol Med. 1962; 111: 544-47.

DOI and Others

DOI: JCDR/2012/3877:2002

Financial OR OTHER COMPETING INTERESTS:
None.
Date Of Submission: Dec 28, 2011
Date Of Peer Review: Jan 01, 2012
Date Of Acceptance: Jan 19, 2012
Date Of Publishing: Apr 15, 2012

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com